Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy.

MLA

de Franceschi, L., et al. “Combination Therapy of Erythropoietin, Hydroxyurea, and Clotrimazole in a Beta Thalassemic Mouse: A Model for Human Therapy.” Blood, vol. 87, no. 3, Feb. 1996, pp. 1188–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8562946&authtype=sso&custid=ns315887.

APA

de Franceschi, L., Rouyer-Fessard, P., Alper, S. L., Jouault, H., Brugnara, C., & Beuzard, Y. (1996). Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a beta thalassemic mouse: a model for human therapy. Blood, 87(3), 1188–1195.

Chicago

de Franceschi, L, P Rouyer-Fessard, S L Alper, H Jouault, C Brugnara, and Y Beuzard. 1996. “Combination Therapy of Erythropoietin, Hydroxyurea, and Clotrimazole in a Beta Thalassemic Mouse: A Model for Human Therapy.” Blood 87 (3): 1188–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8562946&authtype=sso&custid=ns315887.